美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

OncoMed Pharmaceuticals, Inc.

0.8900

+0.0000

成交量：- -

成交額：- -

市值：3,443.42萬

市盈率：-4.22

高：0.8900

開：0.8900

低：0.8900

收：0.8900

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

OncoMed Pharmaceuticals, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.oncomed.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Oncomed Pharmaceuticals, Inc.作為一家臨床階段的生物技術公司於2004年7月在特拉華州成立。公司致力於發現和開發對抗腫瘤干細胞的類單克隆抗體藥物。公司的業務和工作地點位於加利福尼亞州紅木城。其候選產品的目標是干細胞自我更新和通過阻斷腫瘤干細胞和大部分腫瘤細胞，以驅動細胞向非致瘤性狀態分化。公司認為，其候選產品不同於目前的化療，有顯著影響癌症治療與臨床結果的可能。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OMED/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OMED\",,,,,undefined,":{"symbol":"OMED","market":"US","secType":"STK","nameCN":"OncoMed Pharmaceuticals, Inc.","latestPrice":0.89,"timestamp":1557432000000,"preClose":0.89,"halted":3,"volume":0,"delay":0,"floatShares":26086382,"shares":38690089,"eps":-0.210727,"marketStatus":"停牌","change":0,"latestTime":"04-28 13:48:54 EDT","open":0.89,"high":0.89,"low":0.89,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.210727,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745870400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1374120000000,"exchange":"NASDAQ","adjPreClose":0.89,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OMED\",,,,,undefined,":{"symbol":"OMED","floatShares":26086382,"roa":"--","roe":"--","lyrEps":-0.210727,"shares":38690089,"dividePrice":0,"high":0.89,"amplitude":0,"preClose":0.89,"low":0.89,"week52Low":0.5467,"pbRate":"0.71","week52High":3.35,"institutionHeld":0,"latestPrice":0.89,"eps":-0.210727,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.210727,"open":0.89,"prevYearClose":0.89},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.oncomed.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Oncomed Pharmaceuticals, Inc.作為一家臨床階段的生物技術公司於2004年7月在特拉華州成立。公司致力於發現和開發對抗腫瘤干細胞的類單克隆抗體藥物。公司的業務和工作地點位於加利福尼亞州紅木城。其候選產品的目標是干細胞自我更新和通過阻斷腫瘤干細胞和大部分腫瘤細胞，以驅動細胞向非致瘤性狀態分化。公司認為，其候選產品不同於目前的化療，有顯著影響癌症治療與臨床結果的可能。","exchange":"NASDAQ","name":"OncoMed Pharmaceuticals, Inc.","nameEN":"OncoMed Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OMED\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OMED\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-03-07","symbol":"OMED","fiscalQuarterEnding":"2018/12","expectedEps":-0.22,"name":null,"time":"","type":"earning","dateTimestamp":1551934800000,"reportTimeType":"","actualEps":-0.07},{"market":"US","date":"2018-11-01","symbol":"OMED","fiscalQuarterEnding":"2018/09","expectedEps":-0.2,"name":null,"time":"","type":"earning","dateTimestamp":1541044800000,"reportTimeType":"","actualEps":0.16},{"market":"US","date":"2018-08-02","symbol":"OMED","fiscalQuarterEnding":"2018/06","expectedEps":-0.23,"name":null,"time":"","type":"earning","dateTimestamp":1533182400000,"reportTimeType":"","actualEps":-0.1},{"market":"US","date":"2018-05-08","symbol":"OMED","fiscalQuarterEnding":"2018/03","expectedEps":-0.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1525752000000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2018-03-08","symbol":"OMED","fiscalQuarterEnding":"2017/12","expectedEps":-0.31,"name":null,"time":"盤後","type":"earning","dateTimestamp":1520485200000,"reportTimeType":"post","actualEps":0.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OMED\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OMED\",market:\"US\",delay:false,,,undefined,":{}}}